# Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Study · id `cardio:ct-nct02494895` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02494895](<https://clinicaltrials.gov/study/NCT02494895>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02494895

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3056 participants.

## Technical summary

Registry record NCT02494895. Randomized; no masking; primary purpose treatment. Start 2015-08-01 (actual); primary completion 2023-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3056 participants (planned count; ClinicalTrials.gov record NCT02494895, source copy `cardio:ctgov-nct02494895-2018-06-20`, retrieved 2026-10-31)
- Started: 2015-08-01 (actual) (ClinicalTrials.gov record NCT02494895, source copy `cardio:ctgov-nct02494895-2018-06-20`, retrieved 2026-10-31)
- Primary completion: 2023-05 (anticipated) (ClinicalTrials.gov record NCT02494895, source copy `cardio:ctgov-nct02494895-2018-06-20`, retrieved 2026-10-31)
- Completion: 2023-05 (anticipated) (ClinicalTrials.gov record NCT02494895, source copy `cardio:ctgov-nct02494895-2018-06-20`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02494895, source copy `cardio:ctgov-nct02494895-2018-06-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02494895-2018-06-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Ticagrelor monotherapy
- Intervention (Drug): Ticagrelor with Aspirin DAPT(dual antiplatelet treatment)
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: c6558143f322342fa81443a3a151f3834fe3672b58b97ced9a8937b3a306c648
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
